Evidence analysisOctober 27, 2026Health & Science
Outcomes of home-based versus facility-based care for mild diphtheria during a large epidemic in Kano State, Nigeria: A retrospective matched cohort study

FreedomWitness Evidence Engine: This is an AI-assisted original analysis built from the linked source and available public source context. It separates evidence from interpretation and may challenge conventional framing only where the evidence supports it. It is not a copied article.
Outcomes of Home-Based Versus Facility-Based Care for Mild Diphtheria During a Large Epidemic in Kano State, Nigeria
This article summarizes evidence from a retrospective matched cohort study published in PLOS Medicine (October 2026) examining the results of home-based care compared to facility-based care for mild diphtheria cases during a major epidemic in Kano State, Nigeria. The study was conducted by Médecins Sans Frontières (MSF) in collaboration with local health authorities amidst an overwhelmed health system having to manage over 40,000 confirmed diphtheria cases nationally by early 2026.
What is Established
- Diphtheria is a serious bacterial infection traditionally managed in hospitals with diphtheria antitoxin (DAT), antibiotics, and monitoring for complications due to the risk of toxin-mediated damage.
- During large epidemics in resource-constrained settings, hospital capacity and resources become insufficient to treat all patients.
- Kano State experienced Nigeria’s largest recorded diphtheria epidemic starting December 2022, with thousands of confirmed cases stressing the health system.
- MSF introduced a home-based care model (HBC) in mid-2023 for patients with mild diphtheria, including antibiotic treatment at home, follow-up visits, and a referral pathway if symptoms worsened.
- Inpatient treatment continued for severe cases with administration of DAT and close monitoring in diphtheria treatment centres (DTCs).
What the Source Claims
- The study compared 669 mild diphtheria patients matched by age, sex, vaccination status, and area of residence who received either HBC or DTC care.
- Primary outcomes assessed were mortality, long-term complications, and household transmission of diphtheria.
- The data were collected via MSF registries and household interviews conducted roughly 14 months after initial notification (median 421 days).
- After adjustment for age, vaccination status, and treatment delay, HBC was associated with a lower mortality odds ratio (OR 0.36; 95% CI 0.12 to 1.07; p=0.066), though this did not reach conventional levels of statistical significance.
- Treatment delay was significantly associated with increased mortality (OR 1.29 per day delay; 95% CI 1.00 to 1.67; p=0.048).
- Vaccination was associated with lower mortality risk (OR 0.32; 95% CI 0.10 to 0.98; p=0.047).
- Home-based care was not associated with increased rates of household transmission or long-term sequelae compared to facility care.
- The study notes that patients and caregivers reported high acceptability for both care modalities.
- Authors conclude that, when supported by careful clinical triage, prompt antibiotic treatment, and structured follow-up, decentralised home-based care could be a viable option during large diphtheria outbreaks with limited hospital capacity.
What May Be Missing from the Usual Framing
- The study did not include randomized assignment to the care modalities; allocation was based on clinical triage, which may have introduced residual confounding, particularly by disease severity.
- Only patients initially assessed as having mild diphtheria were included, limiting conclusions about broader diphtheria severity spectra.
- The relatively small number of deaths (24) limits the statistical power to detect differences and could widen confidence intervals.
- Replacement patients matched for demographic factors were included when original patients could not be interviewed, potentially affecting comparability.
- The study did not evaluate specific clinical or biochemical markers of severity or toxin exposure to directly adjust for these factors in outcome comparisons.
- The long median interval between notification and interview (over a year) could influence recall accuracy and completeness of reported sequelae or transmission events.
- Structural issues like access to antibiotics, quality of follow-up, and adherence to treatment at home versus facility settings were not measured directly.
Competing Evidence or Uncertainty
- Previous research and outbreak reports have emphasized the importance of hospital-based management for diphtheria due to risk of rapid deterioration and complications treated with DAT.
- The scarcity of diphtheria antitoxin globally and in outbreak settings calls into question the sustainability of hospital-centred care models where inpatient capacity is limited.
- Alternatives like home-based care are under-researched, particularly regarding safety, transmission risk in households, and long-term outcomes.
- The possibility that patients with unrecognized severe disease might have been managed at home cannot be excluded, potentially confounding outcomes.
- The balance of risk versus health system capacity constraints requires context-specific evidence to guide policy and practice.
Why It Matters
- As diphtheria reemerges in parts of Africa and other regions, overwhelmed health systems require adaptable care models to avoid excess mortality and morbidity.
- The findings suggest that carefully structured home-based care might at least partially relieve pressure on scarce inpatient resources without compromising critical outcomes in mild diphtheria cases.
- Routine vaccination and early treatment initiation remain crucial determinants of survival, emphasizing preventive and prompt care aspects over care setting alone.
- Understanding the safety and effectiveness of decentralized care could impact outbreak response policies, especially in low-resource contexts with high caseloads.
- The study’s lessons have relevance for managing other infectious diseases where hospital capacity is similarly limited during epidemics.
What to Verify Next
- The accuracy and completeness of triage criteria used to categorize disease severity and guide treatment location.
- Whether home-based care protocols were consistently implemented, including frequency and quality of follow-up visits and referral adherence.
- The robustness of mortality and transmission outcome measures given potential recall bias and data limitations.
- Evidence from randomized controlled trials or prospective studies comparing home-based care against facility-based care to better control for confounding factors.
- Long-term surveillance data on diphtheria sequelae and household secondary attack rates from diverse settings implementing home-based care.
- The availability, quality, and timeliness of diphtheria antitoxin treatments across different care settings in outbreak contexts.
- Patient and caregiver perspectives on acceptability, challenges, and preferences for home versus facility care.
Readers interested in the full details, methodology, and dataset limitations are encouraged to consult the original study published in PLOS Medicine.
Source & verification
Primary source: PLOS Medicine · October 26, 2026
FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.
Continue reading

Borrelia duttonii
Borrelia duttonii: An Evidence Dossier What is Established Borrelia duttonii is a species of spirochete bacteria known to cause tick-borne relapsing fever (TBRF) predominantly…

Transplant-Associated Ehrlichia ewingii Infection in Pediatric Liver Recipient, United States, 2023
Evidence Dossier: Transplant-Associated Ehrlichia ewingii Infection in a Pediatric Liver Recipient, United States, 2023 What is Established Ehrlichiosis is a tickborne illness caused by…

DARWIN EU Advisory Board meeting: 14 November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 November 2025, 09:00 (CET) to 14 November 2025, 13:00 (CET)
What is established On November 14, 2025, the European Medicines Agency (EMA) held an online meeting of the Data Analysis and Real World Interrogation…